Bleichroeder Acquisition III

This filing materially dictates deal viability by contractually securing sponsor and seller voting compliance, anchoring completion to a hard $150,000,000 net cash threshold that directly links public trust liquidity to transaction success, and structuring a multi-year outside date with conditional extensions. The combined PIPE capital of approximately $350,000,000 funds the $1,600,000,000 acquisition framework and structurally insulates against heavy redemptions. Leadership consolidation under Blitzer and Shannon signals active sponsor execution capacity, while the highly tiered equity structure (compound dividend accruals, dollar-priority liquidation preferences, and veto-capable protective provisions) introduces capitalization complexity that investors must stress-test against disclosed government procurement cycles, flight test execution risks, and supply chain dependencies.

For investors tracking redemption calendars and trust preservation, the disclosure locks the trust floor at $345,000,000 with zero pre-deal distributions, confirming the baseline liquidity pool available for shareholder exits once operations begin. The 24-month operational timeframe starts precisely at the July 8, 2026 IPO close, defining the hard deadline before automatic liquidation protocols activate, though no extension mechanism or amendment to the completion window is introduced. The $14,700,000 deferred underwriting liability establishes a fixed structural deduction from trust balances upon deal closure or dissolution, directly modeling net proceeds to remaining equity. Sponsor conduct is transparently bounded: founder shares carry mandatory one-for-one conversion, redemption waivers apply to insiders, and the $600,000 plus $18,000 monthly advisory fee drains exclusively from the $1,467,629 outside-trust working capital, requiring executives to manage pre-combination burn rate without touching protected trust funds. Because the filing solely documents IPO settlement, audited pre-operation financials, and codified shell-company covenants, it does not shift existing public calendar dates or announce target selection, but it permanently anchors the trust composition, sponsor indemnity posture, and working-capital constraints that will govern all future deal-progress and redemption disclosures.

This filing establishes the SPAC's baseline financial structure (a classic $10.00/share trust with a 24-month deadline) and governing mechanics. All future redemption deadlines, deal negotiations, and proxy statements will reference this founding trust amount, warrant terms, and the 24-month deadline. The document confirms standard SPAC mechanics: (1) the trust holds $10.00 per public share; (2) the 24-month countdown started July 8, 2026; (3) founder and sponsor securities are subject to standard lock-ups; (4) public shareholders have redemption rights in connection with a business combination or certain charter amendments; (5) the business combination must target net assets of at least 80% of the trust balance.

The prospectus and management biographies assert a strategy targeting North American and European businesses in disruptive growth sectors transformed via technology adoption, citing the co-founders’ operational experience. The document attributes specific prior SPAC outcomes to the team: Bleichroeder Acquisition Corp. I closed its merger with Merlin Labs, Inc. on March 16, 2026, referencing a $105 million United States Special Operations Command contract and a U.S. Air Force agreement; Bleichroeder Acquisition Corp.

First public disclosure of BCCQ's structure and terms. Provides redemption mechanics, trust size ($10.00 per share), deadline (24 months from closing, likely 2028), dilution from founder shares, sponsor incentives, and conflicts. Investors need this to evaluate the SPAC's risk/reward. Also details prior SPAC track record of management.

According to the filing, these mechanics directly govern shareholder liquidity windows and redemption pricing relative to the trust balance, which the prospectus calculates could result in Adjusted NTBVPS ranging from $7.09 to $9.81 depending on redemption levels. The prospectus explicitly attributes dilution risks and conflict of interest warnings to the nominal founder share cost and the sponsor's $5,000,000 private placement commitment alongside $2,000,000 convertible working capital loan authority.

What changed: Bleichroeder Acquisition Corp. III filed Form 425 to disseminate a communication regarding the proposed business combination with Mach X and Ursa Major, which will serve as both a proxy statement for Mach X shareholders and a prospectus for securities issued in the transaction. Why it matters: This filing initiates the formal solicitation of proxies from Mach X shareholders to approve the Business Combination, marking a critical procedural step toward closing the deal before the SPAC's July 7, 2028 deadline.

What changed: The filing is a Form 425 communication regarding the proposed Business Combination between Mach X and Ursa Major, filed by Bleichroeder Acquisition Corp. III (BCCQ). It announces that a definitive proxy statement/prospectus will be mailed to Mach X shareholders after the Registration Statement is declared effective. The document contains standard legal disclaimers identifying participants in the solicitation (Mach X directors/officers and Ursa Major directors/officers/employees) and lists extensive risk factors related to the combination, including the risk of missing BCCQ's initial business combination deadline on 2028-07-07, potential shareholder redemptions, regulatory approvals, and operational risks for Ursa Major such as test failures or contract protests. No specific financial figures, redemption prices, or new deal terms are provided in this text; it serves as a notice of upcoming documentation. Why it matters: This filing confirms the procedural next step in the BCCQ-Ursa Major/Mach X transaction: the imminent distribution of definitive voting materials to SPAC shareholders. For investors tracking redemption deadlines, it reinforces that the 2028-07-07 deadline remains a critical constraint cited in the risk factors, though no immediate vote date is set. It alerts investors to review the forthcoming Registration Statement and Proxy Statement for material changes to valuation, sponsor conduct details, or specific redemption mechanics, as this current text contains only forward-looking statements and risk disclosures without binding commercial terms.

What changed: The filing is a Form 425 communication announcing that the definitive proxy statement/prospectus for the business combination between Mach X and Ursa Major, facilitated by SPAC Bleichroeder Acquisition Corp. III, will be mailed to Mach X shareholders after the Registration Statement is declared effective. It identifies participants in the solicitation (Mach X and Ursa Major management/directors) and lists forward-looking statements and risk factors regarding the deal, including potential redemptions, regulatory approvals, and operational risks for Ursa Major. Why it matters: This document serves as the primary informational notice to investors regarding the upcoming vote on the merger, detailing the timeline for receiving definitive materials and outlining the specific risks and forward-looking claims made by the companies' management that investors must consider before voting or deciding whether to redeem their shares.

What changed: The filing is a Form 425 containing a transcript of an investor webcast announcing the business combination agreement between Ursa Major Technologies, Inc. and Inflection Point Mach 10 (the SPAC). The document details that the combined company will trade on NASDAQ under the ticker IPXX and expects completion in the first quarter of 2027. It provides specific financial projections from Ursa Major CEO Chris Bagnoletti: 2024 revenue was $18.5 million, 2025 revenue was $45 million, 2026 revenue is expected to be $100 million, and 2027 revenue is targeted at approximately $200 million. The transcript cites a near-term pipeline of about $2.8 billion and states current production capacity is around 8 Havoc missiles per year, scaling to 500 units per year with transaction proceeds. It also lists key customers including the US Navy, Air Force, BAE Systems, and RTX. Why it matters: This filing establishes the commercial narrative and financial targets for the proposed merger, providing investors with specific revenue growth trajectories and production scale-up plans that justify the valuation and strategic rationale. By attributing these figures to the CEO and management team, it highlights the operational milestones (such as flight tests and manufacturing capabilities) that the sponsor claims will drive future performance, while simultaneously outlining the risks associated with government contract awards and production execution.

What changed: Bleichroeder Acquisition Corp. III (BCCQ) filed Form 425 to announce a definitive business combination agreement with Ursa Major Technologies, Inc., which will rename the combined entity to Inflection Point Mach X Bleichroeder and trade on Nasdaq as IPXX. The filing discloses a pre-money equity valuation of approximately $1.6 billion and a post-transaction equity valuation of approximately $2.3 billion. It confirms at least $350 million in PIPE commitments, with approximately $110 million funded at signing, anchored by sponsor Inflection Point Asset Management. The transaction is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals. Why it matters: This filing establishes the financial terms and strategic direction for BCCQ's target, moving from a blank check company to an active defense manufacturer focused on hypersonics and solid rocket motors. The $350 million PIPE provides significant capital to scale production capabilities, directly impacting the trust value dynamics through potential redemptions (up to $345 million in additional proceeds may be retained depending on redemption levels). Investors should note the specific deadline of July 7, 2028, remains the final date for completing this business combination, and the closing timeline is projected for Q1 2027.

What changed: The filing is a Form 425 submitted by Bleichroeder Acquisition Corp. III (the SPAC) in connection with the proposed business combination with Ursa Major Technologies, Inc. The document contains internal employee communications and an email from CEO C Spag announcing that Ursa Major has signed a business combination agreement with Inflection Point Acquisition Corp., the SPAC sponsor. Key terms disclosed include a $1.6B pre-money valuation, a $350M PIPE commitment (with ~$110M available at signing), and a closing expected in Q1 2027. The SPAC will be renamed 'Inflection Point Mach X Bleichroeder Corp.' and domesticate as a Delaware corporation. The filing also includes standard forward-looking statements and risk factors regarding the transaction. Why it matters: This filing confirms the specific financial structure of the deal, including the significant pre-funding of the PIPE ($110M at signing) which the company claims mitigates redemption risk. It establishes the timeline for the de-SPAC process (signing now, closing Q1 2027) and identifies the new trading entity name. For investors, it provides the first public details on the valuation jump to $1.6B pre-money and the involvement of Inflection Point Asset Management, while the inclusion of internal emails highlights the material non-public information (MNPI) controls and the narrative being pushed to employees regarding customer confidence and operational continuity.

What changed: The filing is a Form 425 customer communication from Ursa Major Technologies, Inc. announcing that it has selected Inflection Point Mach X Bleichroeder Corp. (formerly Bleichroeder Acquisition Corp. III) as its SPAC merger partner, reversing prior expectations or competing processes. The communication states the transaction values Ursa Major at $2.3B post-money and provides at least $350M in committed capital, with an expected closing in Q1 2027. It confirms the SPAC will rename to 'Inflection Point Mach X Bleichroeder Corp.', domesticate from Cayman Islands to Delaware, and list on Nasdaq. The document also lists extensive forward-looking statements and risk factors regarding the business combination, including risks related to redemption requests, financing conditions, regulatory approvals, and operational performance of hypersonic systems. Why it matters: This filing confirms the specific target company (Ursa Major) and the commercial terms ($2.3B valuation, $350M capital) for Bleichroeder Acquisition III's pending business combination, which was previously only known by the SPAC name. It establishes the timeline for the de-SPAC transaction (Q1 2027) and highlights key risks for shareholders, particularly the potential impact of redemptions on liquidity and listing status, and the dependency on obtaining shareholder approval and financing. For investors tracking the deal, this provides the definitive public announcement of the merger partner and initial financial metrics, moving the event from speculation to announced execution phase.

What changed: Form 8-K Current Report and Rule 425 Written Communication announcing a Business Combination Agreement. FIRST, this document is a Form 8-K Current Report and Rule 425 Written Communication announcing a Business Combination Agreement. SECOND, reporting mechanics: The Business Combination Agreement establishes an Outside Date of August 24, 2027, with an automatic extension granting one calendar day per calendar day after October 31, 2026 for delayed financial statements, solely applicable to Ursa Major’s termination right, per the agreement. The Minimum Cash Condition requires that trust account cash (post-redemptions) plus aggregate gross Closing PIPE proceeds, less underwriting fees and transaction costs, equal or exceed $150,000,000, waivable solely by Ursa Major, as defined in the agreement. A Sponsor Support Agreement signed by Bleichroeder Sponsor 3 LLC and Inflection Point Fund I, LP mandates restricted holders vote for Transaction Proposals, waive anti-dilution rights on Cayman Class B Ordinary Share conversions, and oppose alternatives, per the sponsor support terms. Lock-Up Agreements restrict Sponsor Founder Shares for six months and Sponsor Warrants for 30 days, while Seller Lock-Up Agreements restrict seller securities for six months, per the lock-up agreements. THIRD, reporting substance: The Aggregate Consideration applies a purchase price of $1,600,000,000 divided by $10.00, which equates to 160,000,000 shares of New Ursa Major Common Stock, per the Business Combination Agreement. Forward-Looking Statements detail the target’s strategy around hypersonic systems, solid rocket motors, and in-space mobility solutions, alongside government contract funding dependencies and prime contractor relationships, per that section. Per Item 5.02, Michael Blitzer was appointed Chairman and Kevin Shannon was appointed Co-CEO effective August 24, 2026, with Andrew Gundlach and Marcello Padula continuing as director and Co-CEO respectively. The Closing PIPE Investment commits approximately $242.5 million for 20,208,328 Series A Preferred Stock shares at a $12.00 stated value, accruing 10.0% annual dividends if paid in kind or 8.0% if paid in cash, compounding semi-annually, per the Series A SPAs. A Pre-Funded PIPE Investment delivers approximately $107.5 million for 10,539,215 shares, per the other events section. Protective provisions require approval by holders of more than 50% of issued preferred stock for major actions, while permitting up to $50 million in asset-based financing and $30 million under a J.P. Morgan senior secured facility without consent, per the certificate of designation. Why it matters: This filing materially dictates deal viability by contractually securing sponsor and seller voting compliance, anchoring completion to a hard $150,000,000 net cash threshold that directly links public trust liquidity to transaction success, and structuring a multi-year outside date with conditional extensions. The combined PIPE capital of approximately $350,000,000 funds the $1,600,000,000 acquisition framework and structurally insulates against heavy redemptions. Leadership consolidation under Blitzer and Shannon signals active sponsor execution capacity, while the highly tiered equity structure (compound dividend accruals, dollar-priority liquidation preferences, and veto-capable protective provisions) introduces capitalization complexity that investors must stress-test against disclosed government procurement cycles, flight test execution risks, and supply chain dependencies.

What changed: Bleichroeder Acquisition Corp. III (Mach X) filed a Form 8-K on August 25, 2026, reporting the entry into a Business Combination Agreement with Ursa Major Technologies, Inc. on August 24, 2026. The deal values Ursa Major at a Purchase Price of $1,600,000,000, resulting in the issuance of 160,000,000 shares of New Ursa Major Common Stock to Ursa Major shareholders. The transaction includes a Closing PIPE Investment of approximately $242.5 million for 20,208,328 shares of Series A Preferred Stock and warrants, and a Pre-Funded PIPE Investment of approximately $107.5 million by Inflection Point Fund I, LP and others. Mach X will domesticate from the Cayman Islands to Delaware. Michael Blitzer and Kevin Shannon were appointed Chairman and Co-CEO, respectively. The filing does not report any specific redemption deadline changes or trust value adjustments beyond the standard Minimum Cash Condition requiring $150,000,000 in post-redemption cash. Why it matters: This filing confirms the definitive terms of the merger between SPAC BCCQ and Ursa Major, establishing the $1.6 billion valuation and the structure of the equity consideration. It details significant PIPE financing ($350 million total) which supports the Minimum Cash Condition, reducing redemption risk if executed as planned. The appointment of new leadership (Blitzer/Shannon) signals a change in management control aligned with the Sponsor's other recent deals. Investors should note the complex capital structure involving Series A Preferred Stock with 10% dividends, put/call rights, and anti-dilution protections, as well as the domestication process which may trigger redemption rights for public shareholders.

What changed: Quarterly report on Form 10-Q for Bleichroeder Acquisition Corp. III, a blank-check company that had just completed its IPO and had no operations during the period. This is the company's first 10-Q covering the period from inception (April 1, 2026) through June 30, 2026. The filing reports a net loss of $2,078,048, driven primarily by $2,015,750 in share-based compensation expense, and a shareholders' deficit of $37,298. Subsequent to the quarter, on July 8, 2026, the company closed its IPO of 34,500,000 units at $10.00 each, generating $345,000,000 in gross proceeds, which along with $8,500,000 from a private placement of warrants, was deposited into a trust account ($10.00 per public share). The trust is initially invested in U.S. government obligations. The company has 24 months (until July 2028) to complete a business combination. The filing reports no cash on hand as of June 30, 2026, but management asserts sufficient liquidity post-IPO. There is no redemption deadline, extension vote, or pending deal disclosed; the company is still searching. Why it matters: This filing establishes the baseline financial position and trust value for a newly-public SPAC. The trust holds exactly $10.00 per public share, the full $345 million from the IPO, giving investors a clear redemption floor. The significant share-based compensation expense in the pre-IPO period (related to founder shares granted to officers) is now in the rearview mirror. The disclosure of a $527,974 working capital deficit at June 30, 2026, which was alleviated by the IPO, highlights the sponsor's funding role. The company's stated focus is North American and European businesses in disruptive growth sectors. The absence of any business combination target or extension request means investors face a 24-month clock starting July 2026.